Evidence map›Paper›PMID 33734376›Full record

ArticleGenetics2021

Genetic analysis of Pycr1 and Pycr2 in mice.

Morgane G Stum, Abigail L D Tadenev, Kevin L Seburn, Kathy E Miers, Pak P Poon, Christopher R McMaster, Carolyn Robinson, Coleen Kane, Kathleen A Silva, Paul F Cliften and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Cytoplasmic region of beta-dystroglycan is essential for postsynaptic maturation and neuromuscular function in mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Morgane G StumThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Abigail L D TadenevThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Kevin L SeburnThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Kathy E MiersThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Pak P PoonDepartment of Pharmacology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Christopher R McMasterDepartment of Pharmacology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Carolyn RobinsonDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Coleen KaneThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Kathleen A SilvaThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Paul F CliftenDepartment of Genetics, Washington University School of Medicine, St Louis, MO 63110, USA.
John P SundbergThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Laura G ReinholdtThe Jackson Laboratory, Bar Harbor, ME 04609, USA.ORCID 0000-0003-4054-4048
Simon W M JohnThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Robert W BurgessThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Jackson Laboratory · USDalhousie University · CAHoward Hughes Medical Institute · USWashington University in St. Louis · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)UM1OD023222 · OD · JACKSON LABORATORY · PI ROBERT E BRAUN, Stephen A Murray · 2016 to 2026
$47.2M
Factors Determining Intraocular Pressure and Glaucoma SusceptibilityR01EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 2002 to 2018
$12.4M
The Jackson Laboratory Center for Precision Genetics: From New Models to Novel TherapeuticsU54OD020351 · OD · JACKSON LABORATORY · PI SERREZE, DAVID V · 2015 to 2019
$10.2M
Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR01NS054154 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2006 to 2019
$6.0M
The Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR37NS054154 · NINDS · JACKSON LABORATORY · PI Robert W. Burgess · 2020 to 2026
$5.9M
Mouse Mutant ResourceP40OD010972 · OD · JACKSON LABORATORY · PI BERGSTROM, DAVID ERIC, REINHOLDT, LAURA G · 2012 to 2015
$3.4M
Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR56NS054154 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2015 to 2015
$613k
Discovering Novel Gene Networks for Skin DiseasesR21AR063781 · NIAMS · JACKSON LABORATORY · PI SUNDBERG, JOHN PAUL · 2013 to 2014
$422k
FACTORS DETERMINING INTRAOCULAR PRESSURER29EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 1997 to 2001
$227k
Mouse Models of Neurological DiseaseR21OD011163 · OD · JACKSON LABORATORY · PI DONAHUE, LEAH RAE B, REINHOLDT, LAURA G · 2012 to 2012
$211k
NCI NIH HHS P30 CA034196NEI NIH HHS R01 EY011721NEI NIH HHS R29 EY011721NIAMS NIH HHS R21 AR063781NIH HHS P40 OD010972NIH HHS R21 OD011163NIH HHS U54 OD020351NIH HHS UM1 OD023222NINDS NIH HHS R01 NS054154NINDS NIH HHS R37 NS054154NINDS NIH HHS R56 NS054154
6 · The paper itself

Abstract

The final step in proline biosynthesis is catalyzed by three pyrroline-5-carboxylate reductases, PYCR1, PYCR2, and PYCR3, which convert pyrroline-5-carboxylate (P5C) to proline. Mutations in human PYCR1 and ALDH18A1 (P5C Synthetase) cause Cutis Laxa (CL), whereas mutations in PYCR2 cause hypomyelinating leukodystrophy 10 (HLD10). Here, we investigated the genetics of Pycr1 and Pycr2 in mice. A null allele of Pycr1 did not show integument or CL-related phenotypes. We also studied a novel chemically-induced mutation in Pycr2. Mice with recessive loss-of-function mutations in Pycr2 showed phenotypes consistent with neurological and neuromuscular disorders, including weight loss, kyphosis, and hind-limb clasping. The peripheral nervous system was largely unaffected, with only mild axonal atrophy in peripheral nerves. A severe loss of subcutaneous fat in Pycr2 mutant mice is reminiscent of a CL-like phenotype, but primary features such as elastin abnormalities were not observed. Aged Pycr2 mutant mice had reduced white blood cell counts and altered lipid metabolism, suggesting a generalized metabolic disorder. PYCR1 and -2 have similar enzymatic and cellular activities, and consistent with previous studies, both were localized in the mitochondria in fibroblasts. Both PYCR1 and -2 were able to complement the loss of Pro3, the yeast enzyme that converts P5C to proline, confirming their activity as P5C reductases. In mice, Pycr1; Pycr2 double mutants were sub-viable and unhealthy compared to either single mutant, indicating the genes are largely functionally redundant. Proline levels were not reduced, and precursors were not increased in serum from Pycr2 mutant mice or in lysates from skin fibroblast cultures, but placing Pycr2 mutant mice on a proline-free diet worsened the phenotype. Thus, Pycr1 and -2 have redundant functions in proline biosynthesis, and their loss makes proline a semi-essential amino acid. These findings have implications for understanding the genetics of CL and HLD10, and for modeling these disorders in mice.

Indexed as

AnimalsFemaleHumansMaleMiceMice, Inbred C57BLMutationPhenotypeProlinePyrroline Carboxylate ReductasesProlinePyrroline Carboxylate Reductasesadipocytecutis laxaelastinhypomyelinating leukodystrophymetabolismproline synthesisskin

Identifiers

PMID33734376
PMCPMC8128379
OpenAlexW3136493433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.